---
title: "Fatigue Burden in Compensated Chronic Liver Disease: Multinational a:GAP Survey Findings"
id: "medrxiv-0-burden-of-fatigue-in-compensated-chronic-liver-disease-findings-from-the"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-burden-of-fatigue-in-compensated-chronic-liver-disease-findings-from-the"
content_type: "clinical_feed_article"
specialty: "Gastroenterology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1?rss=1"
published_at: "2026-09-02T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Fatigue Burden in Compensated Chronic Liver Disease: Multinational a:GAP Survey Findings
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-burden-of-fatigue-in-compensated-chronic-liver-disease-findings-from-the
- **Specialty:** [Gastroenterology](https://medichelpline.com/clinical-feed/gastroenterology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1?rss=1)
- **Published At:** 2026-09-02T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This multinational cross-sectional a:GAP survey assessed the burden of **fatigue** in adults with compensated **chronic liver disease (CLD)** in China, India and Mexico between July and November 2024. - A total of 505 participants (China 200, India 200, Mexico 105) who self-reported physician‑diagnosed CLD and current fatigue completed quantitative assessments. - The survey combined symptom burden questions with validated patient‑reported outcome (PRO) instruments: **PROMIS-29+2**, **WPAI: SHP**, and **MFI** to quantify fatigue, mental health, pain, sleep interference and work/activity impairment. - Participants commonly reported moderate (51.3%) or serious (26.9%) fatigue; 33.5% experienced fatigue every day or almost every day. - Fatigue affected self‑esteem/confidence (45.1%) and ability to maintain or obtain employment (38.6%); many reported negative effects on social life (47.3%) and finances (53.9%). - PRO results indicated severe fatigue on the **MFI** (overall mean general fatigue 13.9 [SD 3.4]; physical fatigue 13.4 [SD 3.6]) and substantial work and activity impairment on **WPAI: SHP** (overall mean 53.0 [SD 26.4]). - **PROMIS** T-scores showed elevated anxiety, pain interference, depression and sleep interference (T-scores ≥54). - The authors conclude that **fatigue** substantially reduces **health-related quality of life (HRQoL)** among adults with compensated CLD across countries and identify a global unmet need for targeted identification and management. - The study was funded by Abbott Products Operations AG, approved by country-specific ethics committees, and is a preprint not yet peer reviewed.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Burden of fatigue in compensated chronic liver disease: findings from the multinational a:GAP Study Gourdas Choudhuri, Gamar Akhundova-Unadkat, Nivantha Naidoo, Mauricio Morales-Castillo, Xavier Guillaume, Ruben G Duijnhoven, Azadeh Safaei, Mark G Swain doi: https://doi.org/10.64898/2026.08.28.26361618 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Gourdas Choudhuri 1 Department of Gastroenterology and Hepato-Biliary Sciences, Fortis Memorial Research Institute, Gurugram, Haryana, India; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Gourdas%2BChoudhuri%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Choudhuri%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGourdas%2BChoudhuri%2B) Gamar Akhundova-Unadkat 2 Abbott Products Operations AG, Global Medical Affairs, Allschwil, Switzerland; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Gamar%2BAkhundova-Unadkat%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Akhundova-Unadkat%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGamar%2BAkhundova-Unadkat%2B) Nivantha Naidoo 3 Oracle Health and Life Sciences, Paris, Ile de France, France; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nivantha%2BNaidoo%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Naidoo%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANivantha%2BNaidoo%2B) Mauricio Morales-Castillo 2 Abbott Products Operations AG, Global Medical Affairs, Allschwil, Switzerland; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mauricio%2BMorales-Castillo%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Morales-Castillo%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMauricio%2BMorales-Castillo%2B) Xavier Guillaume 3 Oracle Health and Life Sciences, Paris, Ile de France, France; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Xavier%2BGuillaume%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Guillaume%20X&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AXavier%2BGuillaume%2B) Ruben G Duijnhoven 4 Abbott Laboratories, Global Biometrics and Data Center, Weesp, the Netherlands; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ruben%2BG%2BDuijnhoven%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Duijnhoven%20RG&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARuben%2BG%2BDuijnhoven%2B) Azadeh Safaei 5 Abbott Products Operations AG, Global Medical Affairs, Allschwil, Switzerland.; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Azadeh%2BSafaei%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Safaei%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAzadeh%2BSafaei%2B) Mark G Swain 6 University of Calgary Liver Unit, Calgary, Alberta, Canada * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mark%2BG%2BSwain%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Swain%20MG&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMark%2BG%2BSwain%2B) * For correspondence: swain@ucalgary.ca * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1290136/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1290136/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1290136/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1290136/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1290136/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1290136/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background & Aims: Fatigue is a central symptom of chronic liver disease (CLD), substantially impacting health-related quality of life (HRQoL). This study aimed to further understand CLD symptomatology, including fatigue, and its impact on HRQoL from a patient perspective. Methods: Abbott Global Assessment of Patients unmet needs (aGAP) was a multinational, cross-sectional survey in adults with compensated CLD in China, India and Mexico, conducted between July and November 2024. Adult participants who self-reported that they had physician-diagnosed CLD and were experiencing fatigue completed a quantitative survey to assess symptom burden and included three HRQoL patient-reported outcome (PRO) questionnaires (Patient-Reported Outcomes Measurement Information System [PROMIS]-29+2, Work Productivity and Activity Impairment - Specific Health Problem version 2.0 [WPAI: SHP], Multidimensional Fatigue Inventory [MFI]). Results: Overall, 505 participants (China: 200; Mexico: 105; India: 200) completed the study. Participants reported that their CLD-related fatigue sometimes, often or always affected their self-esteem/confidence (45.1%) and ability to maintain or acquire new employment (38.6%). Most participants reported moderate (51.3%) or serious (26.9%) fatigue, with 33.5% experiencing fatigue every day or almost every day. Many participants felt their social life was negatively impacted by their fatigue (47.3%) and that there were related financial difficulties (53.9%). Use of validated PRO tools demonstrated severe fatigue (MFI: overall mean [SD] 13.9 [3.4] general fatigue and 13.4 [3.6] physical fatigue) as well as substantial levels of work and activity impairment (WPAI: SHP overall mean [SD] 53.0 [26.4]) and high levels of anxiety, pain interference, depression and sleep interference (PROMIS T-scores ≥54). Conclusions: Fatigue has a substantial impact on HRQoL among adults with CLD across several countries, highlighting a global unmet need for targeted interventions to effectively identify and manage the condition. ### Competing Interest Statement GA-U was a full-time employee of Abbott Products Operations AG at the time this work was conducted and the manuscript was developed. NN and XG are employees of Oracle Health and Life Sciences. MM-C, RGD and AS are employees of Abbott Products Operations AG. MGS reports advisory roles for Gilead, Ipsen, Novo Nordisk, Advanz, Abbott, GSK, Mirum, Moderna and Boehringer Ingelheim, speaker activity for Ipsen, Gilead, Abbott, Umecrine, Mirum and Novo Nordisk, and clinical trial funding from Gilead, GSK, Cymabay, Intercept, Kowa, Novo Nordisk, Pfizer, Ancella, Merck, Galectin, Ipsen, Madrigal, Roche, Altimmune, 89Bio, Inventiva, Mirum, Lilly and Boehringer Ingelheim. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study was approved by country-specific Independent Ethics Committees (i.e., India: Royal Pune Independent Ethics committee; China: Shanghai Clinical Research Ethics Committee; Mexico: CEISH-USFQ University of San Francisco Ethics Committee) and conducted according to the principles of the Declaration of Helsinki, Good Pharmacoepidemiology Practices, and Oracle Health and Life Sciences standard operating procedures. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All relevant data are within the paper and its Supporting Information files. ## Funder Information Declared Abbott Products Operations AG Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.30.26361786v1 "Feasibility study of gait analysis using a new Wearable Force Plate")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.28.26361368v1 "GLP-1/GIP Uptake, Indication, and Access Pathways Among US Adults in the Understanding America Study") Posted September 02, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/09/02/2026.08.28.26361618.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.08.28.26361618v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/09/02/2026.08.28.26361618.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Burden of fatigue in compensated chronic liver disease: findings from the multinational a:GAP Study Gourdas Choudhuri, Gamar Akhundova-Unadkat, Nivantha Naidoo, Mauricio Morales-Castillo, Xavier Guillaume, Ruben G Duijnhoven, Azadeh Safaei, Mark G Swain medRxiv 2026.08.28.26361618; doi: https://doi.org/10.64898/2026.08.28.26361618 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.28.26361618v1%26text%3DBurden%2520of%2520fatigue%2520in%2520compensated%2520chronic%2520liver%2520disease%253A%2520findings%2520from%2520the%2520multinational%2520a%253AGAP%2520Study "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.28.26361618v1%26t%3DBurden%2520of%2520fatigue%2520in%2520compensated%2520chronic%2520liver%2520disease%253A%2520findings%2520from%2520the%2520multinational%2520a%253AGAP%2520Study "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.28.26361618v1%26title%3DBurden%2520of%2520fatigue%2520in%2520compensated%2520chronic%2520liver%2520disease%253A%2520findings%2520from%2520the%2520multinational%2520a%253AGAP%2520Study%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.28.26361618v1%26title%3DBurden%2520of%2520fatigue%2520in%2520compensated%2520chronic%2520liver%2520disease%253A%2520findings%2520from%2520the%2520multinational%2520a%253AGAP%2520Study "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.28.26361618) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.28.26361618v1&count=horizontal&via=&text=Burden%20of%20fatigue%20in%20compensated%20chronic%20liver%20disease%3A%20findings%20from%20the%20multinational%20a%3AGAP%20Study&counturl=www.medrxiv.org/content/10.64898/2026.08.28.26361618v1 "Tweet This") ## Subject Area * [Gastroenterology ](https://www.medrxiv.org/collection/gastroenterology) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (614) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (896) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (326) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4770) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (474) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (407) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (643) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1615) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15836) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1195) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6983) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (727) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1057) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4985) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1426) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1737) * [Hematology](https://www.medrxiv.org/collection/hematology) (581) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1336) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16245) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1161) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (663) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (151) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (721) * [Neurology](https://www.medrxiv.org/collection/neurology) (7194) * [Nursing](https://www.medrxiv.org/collection/nursing) (364) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1074) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1231) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1001) * [Oncology](https://www.medrxiv.org/collection/oncology) (3574) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1037) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (393) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (446) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (466) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (139) * [Pathology](https://www.medrxiv.org/collection/pathology) (704) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1774) * [Pharmacology and Therapeutics](https
## Related Clinical Research

- [North West London Diabetes Cohort: multiethnic EHR resource for diabetes complications research](https://medichelpline.com/clinical-feed/bmj-open-2-large-scale-multiethnic-electronic-health-record-resource-for-diabetes.md)
- [Kurort Health Walking in a Forest: Short-Term Physiological and Psychological Effects](https://medichelpline.com/clinical-feed/plos-one-3-physiological-and-psychological-outcomes-of-a-community-based-kurort-health.md)
- [Fitspiration vs Thinspiration: Effects on Body and Functionality Appreciation in Young Chinese Wom](https://medichelpline.com/clinical-feed/plos-one-9-rethinking-fitspiration-in-social-media-experimental-insights-from-young.md)
- [2026 Stroke Rehabilitation Guideline: Start Early and Address Physical, Cognitive, and Mental Heal](https://medichelpline.com/clinical-feed/medical-news-today-0-stroke-rehab-guidelines-emphasize-early-support-for-physical-cognitive-and.md)
- [JITAI trial protocol to reduce pain catastrophising in chronic back pain using EMA-guided microint](https://medichelpline.com/clinical-feed/bmj-open-10-effectiveness-of-a-just-in-time-adaptive-intervention-for-improving-pain.md)

## Navigation
- [← Back to Gastroenterology Feed](https://medichelpline.com/clinical-feed/gastroenterology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.